Optimal cytoreduction in advanced ovarian cancer treated with dose-dense paclitaxel and carboplatin followed by interval surgery at the peruvian national institute of neoplastic diseases

Optimal cytoreduction in advanced ovarian cancer treated with dose-dense paclitaxel and carboplatin followed by interval surgery at the peruvian national institute of neoplastic diseases

Objectives. To determine the rate of optimal cytoreduction in patients with advanced ovarian cancer who received neoadjuvant chemotherapy with dose-dense carboplatin and paclitaxel followed by interval debulking surgery (IDS). Materials and Methods. A retrospective study of a series of cases of Peru...

Full description

Bibliographic Details
Main Authors: Cindy Alcarraz, Johana Muñiz, Luis Mas, Mivael Olivera, Zaida Morante, Manuel Alvarez, Raul Mantilla, Jhajaira Araujo, Joseph Pinto
Format: Article
Language:Spanish
Published: Instituto Nacional de Salud 2018-04-01
Series:Revista Peruana de Medicina Experimental y Salud Pública
Subjects:
neoplasias ováricas
quimioterapia
terapia neoadyuvante
procedimientos quirúrgicos de citorreducción
perú
Online Access:https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/3599

Similar Items

Similar Items